GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NaviFUS Corp (ROCO:6872) » Definitions » Total Tax Payable

NaviFUS (ROCO:6872) Total Tax Payable : NT$0.00 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is NaviFUS Total Tax Payable?

NaviFUS's Total Tax Payable for the quarter that ended in Jun. 2024 was NT$0.00 Mil.


NaviFUS Total Tax Payable Historical Data

The historical data trend for NaviFUS's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NaviFUS Total Tax Payable Chart

NaviFUS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Tax Payable
Get a 7-Day Free Trial - - - - -

NaviFUS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

NaviFUS Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.


NaviFUS Total Tax Payable Related Terms

Thank you for viewing the detailed overview of NaviFUS's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


NaviFUS Business Description

Traded in Other Exchanges
N/A
Address
No.246, Sec 3, Chengde Road, 12th Floor, Datong District, Taipei City, TWN, 103
NaviFUS Corp is a Biotech company providing novel platform solutions for crossing the blood-brain barrier (BBB) for enhanced oncology drug delivery. Its product, the NaviFUS System, is designed to utilize non-invasive ultrasound energy to enable transient and safe enhancement of BBB permeability to facilitate the transport of small or large molecular CNS drugs to target tumor tissue at high precision for better treatment outcomes. Its vision is to cater to CNS disease patients locally and globally by bringing therapeutic ultrasound technology to clinical use.

NaviFUS Headlines

No Headlines